Kuhn v. Secretary of Health and Human Services ( 2015 )


Menu:
  •        In the United States Court of Federal Claims
    OFFICE OF SPECIAL MASTERS
    No. 13-802V
    Filed: January 12, 2015
    * * * * * * * * * * * * * * * *                           UNPUBLISHED
    DEBRA L. KUHN,                              *
    *            Special Master Dorsey
    Petitioner,                    *
    *
    v.                                           *
    *             Joint Stipulation on Damages;
    SECRETARY OF HEALTH                          *             Influenza (Flu) vaccine; Guillain-
    AND HUMAN SERVICES,                          *             Barré Syndrome (GBS)
    *
    Respondent.                    *
    *
    * * * * * * * * * * * * * * * *
    Diana Stadelnikas Sedar, Maglio, Christopher & Toale, PA, Sarasota, FL, for petitioner.
    Julia Wernett McInerny, United States Department of Justice, Washington, DC, for respondent.
    DECISION1
    On October 15, 2013, Debra Kuhn (“petitioner”) filed a petition pursuant to the National
    Vaccine Injury Compensation Program.2 42 U.S.C. §§ 300aa-1 to -34 (2006). Petitioner alleged
    that she suffered from Guillain-Barré syndrome as a result of an influenza (“flu”) vaccine that
    was administered to her on September 13, 2011. See Petition at 1. Petitioner further alleged that
    she experienced the residual effects of these injuries for more than six months. Id. at 2.
    On January 9, 2015, the parties filed a stipulation, stating that a decision should be
    1
    Because this decision contains a reasoned explanation for the undersigned’s action in this case,
    the undersigned intends to post this ruling on the website of the United States Court of Federal
    Claims, in accordance with the E-Government Act of 2002, Pub. L. No. 107-347, § 205, 
    116 Stat. 2899
    , 2913 (codified as amended at 
    44 U.S.C. § 3501
     note (2006)). As provided by
    Vaccine Rule 18(b), each party has 14 days within which to request redaction “of any
    information furnished by that party: (1) that is a trade secret or commercial or financial in
    substance and is privileged or confidential; or (2) that includes medical files or similar files, the
    disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule
    18(b).
    2
    The National Vaccine Injury Compensation Program is set forth in Part 2 of the National
    Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 
    100 Stat. 3755
    , codified as amended,
    42 U.S.C. §§ 300aa-1 to -34 (2006) (Vaccine Act or the Act). All citations in this decision to
    individual sections of the Vaccine Act are to 42 U.S.C.A. § 300aa.
    1
    entered awarding compensation.
    Respondent denies that the flu vaccine caused petitioner’s GBS or any other injury.
    Nevertheless, the parties agree to the joint stipulation, attached hereto as Appendix A. The
    undersigned finds the stipulation reasonable and adopts it as the decision of the Court in
    awarding damages, on the terms set forth therein.
    The parties stipulated that petitioner shall receive the following compensation:
    A lump sum of $165,000.00, in the form of a check payable to petitioner. This amount
    represent compensation for all damages that would be available under 42 U.S.C. § 300aa-
    15(a).
    Stipulation ¶ 8.
    The undersigned approves the requested amount for petitioner’s compensation.
    Accordingly, an award should be made consistent with the stipulation.
    In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of
    the court SHALL ENTER JUDGMENT in accordance with the terms of the parties’
    stipulation.3
    IT IS SO ORDERED.
    s/ Nora Beth Dorsey
    Nora Beth Dorsey
    Special Master
    3
    Pursuant to Vaccine Rule 11(a), entry of judgment is expedited by the parties’ joint filing of
    notice renouncing the right to seek review.
    2
    

Document Info

Docket Number: 13-802

Judges: Nora Beth Dorsey

Filed Date: 2/2/2015

Precedential Status: Non-Precedential

Modified Date: 4/18/2021